Bas M. Peters

St Antonius Hospital, Koekoekslaan 1
Nieuwegein, UT 3435CM, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Reply to letter to the editor "The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non-Small-Cell lung cancer".

Reply to letter to the editor "The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non-Small-Cell lung cancer".

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 01, 2025

Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series.

Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series.

Journal: British journal of clinical pharmacology

Published: March 25, 2025

Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?

Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?

Journal: Clinical lung cancer

Published: March 03, 2025

The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study.

The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study.

Journal: Clinical lung cancer

Published: December 16, 2024

Comparative Effectiveness of Nivolumab and Ipilimumab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in PD-L1 Negative Metastatic Non-Small Cell Lung Cancer Patients.

Comparative Effectiveness of Nivolumab and Ipilimumab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in PD-L1 Negative Metastatic Non-Small Cell Lung Cancer Patients.

Journal: Clinical lung cancer

Published: September 17, 2024

Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study.

Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study.

Journal: Lung

Published: September 11, 2023

The potential for deprescribing in a palliative oncology patient population: a cross-sectional study.

The potential for deprescribing in a palliative oncology patient population: a cross-sectional study.

Journal: European journal of hospital pharmacy : science and practice

Published: November 07, 2021

Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients.

Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients.

Journal: Cells

Published: January 21, 2021

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands.

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands.

Journal: Scientific reports

Published: November 23, 2020

Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer.

Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer.

Journal: Anticancer research

Published: October 19, 2020

Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014.

Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014.

Journal: PharmacoEconomics - open

Published: June 14, 2020

Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer.

Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer.

Journal: Pharmacoepidemiology and drug safety

Published: April 02, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026